Cargando…

The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy

BACKGROUND: The aim of this study is to compare the 2021–2022 bronchiolitis season to the four previous years (2017–2018, 2018–2019, 2019–2020, 2020–2021) to see if there was an anticipation of the peak, an overall increase of cases, and an increased need of intensive care. METHODS: A retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Faraguna, Martha Caterina, Lepri, Irene, Clavenna, Antonio, Bonati, Maurizio, Vimercati, Chiara, Sala, Debora, Cattoni, Alessandro, Melzi, Maria Luisa, Biondi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942300/
https://www.ncbi.nlm.nih.gov/pubmed/36803828
http://dx.doi.org/10.1186/s13052-023-01425-8
_version_ 1784891468345769984
author Faraguna, Martha Caterina
Lepri, Irene
Clavenna, Antonio
Bonati, Maurizio
Vimercati, Chiara
Sala, Debora
Cattoni, Alessandro
Melzi, Maria Luisa
Biondi, Andrea
author_facet Faraguna, Martha Caterina
Lepri, Irene
Clavenna, Antonio
Bonati, Maurizio
Vimercati, Chiara
Sala, Debora
Cattoni, Alessandro
Melzi, Maria Luisa
Biondi, Andrea
author_sort Faraguna, Martha Caterina
collection PubMed
description BACKGROUND: The aim of this study is to compare the 2021–2022 bronchiolitis season to the four previous years (2017–2018, 2018–2019, 2019–2020, 2020–2021) to see if there was an anticipation of the peak, an overall increase of cases, and an increased need of intensive care. METHODS: A retrospective single-centre study in the San Gerardo Hospital Fondazione MBBM, Monza, Italy was performed. Emergency Departments (ED) visits of patients aged < 18 years and ≤ 12 months were analyzed: the incidence of bronchiolitis on total assessments, the urgency level at triage and the hospitalization rate were compared. Data of children admitted to the Pediatric Department due to bronchiolitis were analyzed in terms of need of intensive care, respiratory support (type and duration), length of hospital stay, main etiological agent, patient characteristics. RESULTS: During 2020–2021 (first pandemic period) an important reduction in the ED attendance for bronchiolitis was observed, while in 2021–2022 there was an increase in incidence of bronchiolitis (13% of visits in infants < 1 year) and in the rate of urgent accesses (p = 0.0002), but hospitalization rates did not differ compared to previous years. Furthermore, an anticipated peak in November 2021 was observed. In the 2021–2022 cohort of admitted children to the Pediatric Department, a statistically significative increased need of intensive care unit was detected (Odds Ratio 3.1, 95% CI 1.4–6.8 after adjustment for severity and clinical characteristics). Instead, respiratory support (type and duration) and length of hospital stay did not differ. RSV was the main etiological agent and RSV-bronchiolitis determined a more severe infection (type and duration of breathing support, intensive care need and length of hospital stay). CONCLUSIONS: During Sars-CoV-2 lockdowns (2020–2021), there was a dramatic decrease of bronchiolitis and others respiratory infections. In the following season, 2021–2022, an overall increase of cases with an anticipated peak was observed and data analysis confirmed that patients in 2021–2022 required more intensive care than children in the four previous seasons. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13052-023-01425-8.
format Online
Article
Text
id pubmed-9942300
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99423002023-02-22 The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy Faraguna, Martha Caterina Lepri, Irene Clavenna, Antonio Bonati, Maurizio Vimercati, Chiara Sala, Debora Cattoni, Alessandro Melzi, Maria Luisa Biondi, Andrea Ital J Pediatr Research BACKGROUND: The aim of this study is to compare the 2021–2022 bronchiolitis season to the four previous years (2017–2018, 2018–2019, 2019–2020, 2020–2021) to see if there was an anticipation of the peak, an overall increase of cases, and an increased need of intensive care. METHODS: A retrospective single-centre study in the San Gerardo Hospital Fondazione MBBM, Monza, Italy was performed. Emergency Departments (ED) visits of patients aged < 18 years and ≤ 12 months were analyzed: the incidence of bronchiolitis on total assessments, the urgency level at triage and the hospitalization rate were compared. Data of children admitted to the Pediatric Department due to bronchiolitis were analyzed in terms of need of intensive care, respiratory support (type and duration), length of hospital stay, main etiological agent, patient characteristics. RESULTS: During 2020–2021 (first pandemic period) an important reduction in the ED attendance for bronchiolitis was observed, while in 2021–2022 there was an increase in incidence of bronchiolitis (13% of visits in infants < 1 year) and in the rate of urgent accesses (p = 0.0002), but hospitalization rates did not differ compared to previous years. Furthermore, an anticipated peak in November 2021 was observed. In the 2021–2022 cohort of admitted children to the Pediatric Department, a statistically significative increased need of intensive care unit was detected (Odds Ratio 3.1, 95% CI 1.4–6.8 after adjustment for severity and clinical characteristics). Instead, respiratory support (type and duration) and length of hospital stay did not differ. RSV was the main etiological agent and RSV-bronchiolitis determined a more severe infection (type and duration of breathing support, intensive care need and length of hospital stay). CONCLUSIONS: During Sars-CoV-2 lockdowns (2020–2021), there was a dramatic decrease of bronchiolitis and others respiratory infections. In the following season, 2021–2022, an overall increase of cases with an anticipated peak was observed and data analysis confirmed that patients in 2021–2022 required more intensive care than children in the four previous seasons. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13052-023-01425-8. BioMed Central 2023-02-21 /pmc/articles/PMC9942300/ /pubmed/36803828 http://dx.doi.org/10.1186/s13052-023-01425-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Faraguna, Martha Caterina
Lepri, Irene
Clavenna, Antonio
Bonati, Maurizio
Vimercati, Chiara
Sala, Debora
Cattoni, Alessandro
Melzi, Maria Luisa
Biondi, Andrea
The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy
title The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy
title_full The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy
title_fullStr The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy
title_full_unstemmed The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy
title_short The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy
title_sort bronchiolitis epidemic in 2021–2022 during the sars-cov-2 pandemic: experience of a third level centre in northern italy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942300/
https://www.ncbi.nlm.nih.gov/pubmed/36803828
http://dx.doi.org/10.1186/s13052-023-01425-8
work_keys_str_mv AT faragunamarthacaterina thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT lepriirene thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT clavennaantonio thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT bonatimaurizio thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT vimercatichiara thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT saladebora thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT cattonialessandro thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT melzimarialuisa thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT biondiandrea thebronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT faragunamarthacaterina bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT lepriirene bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT clavennaantonio bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT bonatimaurizio bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT vimercatichiara bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT saladebora bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT cattonialessandro bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT melzimarialuisa bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly
AT biondiandrea bronchiolitisepidemicin20212022duringthesarscov2pandemicexperienceofathirdlevelcentreinnorthernitaly